University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 15 of 27
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
NCT02983305
Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis
NCT03127228
Study of the Safety of KSP Heptapeptide (KSP-910638G)
NCT03161418
Providing Online Counseling for Home-Based HIV Testing With Transgender Youth
NCT03185975
Regenerative Peripheral Nerve Interfaces for the Treatment of Painful Neuromas in Major Limb Amputees
NCT07285486
Pain and Medication Use Following Surgery
NCT03179566
Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care
NCT03084159
Virtual Reality Job Interview Training in Severe Mental Illness
NCT03049813
A Mobile Phone-based Program for Adults With Prediabetes
NCT03025607
A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections
NCT02692651
ECPR for Refractory Out-Of-Hospital Cardiac Arrest
NCT03065647
Wound Complications in Head and Neck Surgery
NCT03134976
Microcurrent Dressing to Treat Infections, Before, During and After Surgery
NCT03156543
Neuroimaging of Anesthetic Modulation of Human Consciousness
NCT03361605
Particulate Matter, Blood Pressure, and the Sympathetic Nervous System
NCT03079843
Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention
NCT02945436
Cognitive Training for the Prevention of Postoperative Delirium
NCT02963961
Genetic Determinants of ACEI Prodrug Activation
NCT03051282
Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary Hypertension
NCT03564522
Neurally Targeted Interventions to Reduce Early Childhood Anxiety
NCT03093376
Intense Pulsed Light Study for Dry Eye Disease
NCT03089580
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
NCT03140631
A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects
NCT03519880
The CardiOvascular Remodeling Following Endovascular Aortic Repair (CORE) Study
NCT02735720
Effects of Early Vestibular Rehabilitation in Patients With Dizziness and Balance Disorders After Sport Concussion
NCT02945605
The Effects of Self-monitoring With a Mobile Application in Heart Failure
NCT03149510
Brain Computer Interface for Communication in Ventilated Patients
NCT02791425
Sonographic Imaging of Oral and Dental Anatomical Structures (A Pilot Study)
NCT03657589
Translation of an Intervention for Violence Among Adolescents in Emergency Departments
NCT02923492
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
NCT02964741
Examining the Impact of Tampon Use on the Vaginal Microbiota
NCT03346759
Mindfulness to the Clinical Setting: The Mind Hand Connection Study
NCT03165799
Self-Management App for Patients With Left-Ventricular Assist Devices
NCT03049748
Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes
NCT03037528
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
NCT03159247
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
NCT02973477
Social Media Alcohol Intervention
NCT02809586
Transcranial Direct Current Stimulation (tDCS) and Intensive Therapy in Aphasia
NCT03510182
A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease
NCT02950818
Mechanisms of Health Literacy and Information Accessibility in the Deaf
NCT03093779
The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy
NCT02891174
Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety
NCT02810171
Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars
NCT02925078
Medication Management Among Individuals With Neurodevelopmental Disabilities
NCT03121651
Relationship Between Postpartum Mood Disorders and Delivery Experience
NCT03004872
Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention
NCT03855410
Virtual Reality Analgesia in Labor: The VRAIL Pilot Study
NCT02926469
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
NCT03350997
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
NCT02789176
Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care
NCT02898584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.